Overview
What is cancer?
During our lifetime, our body normally makes new cells and breaks down old cells. Sometimes cells may grow or divide too much or are not broken down enough, leading to tumors and potentially cancer. Cancers can start in cells in the organs of our bodies, known as solid tumors and include cancers such as lung or skin, or cancer can start in cells in our blood, leading to leukemia, lymphoma or multiple myeloma. Cancer treatment depends on the location(s) and number of tumors, stage of cancer, genetic changes, and more.1
How common is cancer?
Nearly 2 million people are projected to be diagnosed with cancer in 2023 in the US. As many as 1 and 3 people will have a cancer diagnosis in their lifetime. Skin cancer is the most commonly diagnosed type of cancer, followed by breast, prostate, lung and colorectal cancer.2
What screening is recommended for cancer?
Screening is available for certain types of cancers, which can help prevent or reduce the severity of cancer. Screening varies depending on the type of cancer and personal risk factors. For the latest information on when and how to get screened, please visit:
Questions regarding your cancer therapy
You can reach the Accredo oncology care team, anytime, day or night, seven days a week.
24-hour Customer Service Center
- 1What is Cancer? Retrieved August 15, 2023 Understanding Cancer
- 2Cancer Stat Facts: Cancer of Any Site Retrieved August 15, 2023 Cancer.gov
Medications
Accredo, a specialty pharmacy, dispenses specialty cancer medications including (but not limited to):
| Medication | Manufacturer |
|---|---|
| Abraxane® (paclitaxel protein-bound particles for injectable suspension) | Celgene Corporation |
| Adcetris® (brentuximab vedotin) | Seattle Genetics, Inc. |
| Afinitor® (everolimus) | Novartis Pharmaceuticals Corp. |
| Alecensa® (alectinib) | Genentech USA, Inc. |
| Alymsys® (bevacizumab-maly) | Amneal Pharmaceuticals |
| Anktiva® (nogapendekin alfa inbakicept) | ImmunityBio |
| Aranesp® (darbepoetin alfa) | Amgen, Inc. |
| Arranon® (nelarabine) | GlaxoSmithKline |
| Arzerra® (ofatumumab) | Novartis Pharmaceuticals Corp. |
| Avastin® (bevacizumab) | Genentech USA, Inc. |
| Belrapzo® (bendamustine) | Eagle Pharmaceuticals |
| Bendeka® (bendamustine HCl) | Teva Pharmaceutical Industries, Ltd. |
| Besponsa® (inotuzumab ozogamicin) | Pfizer, Inc. |
| Bosulif® (bosutinib) | Pfizer, Inc. |
| Braftovi® (encorafenib) | Pfizer, Inc. |
| Cabometyx® (cabozantinib) | Exelixis, Inc. |
| Columvi™ (glofitamab) | Genentech USA, Inc. |
| Cometriq® (cabozantinib) | Exelixis, Inc. |
| Cotellic™ (cobimetinib) | Genentech USA, Inc. |
| Cyramza® (ramucirumab) | Eli Lilly & Co. |
| Dacogen® (decitabine) | Otsuka America Pharmaceutical, Inc. |
| Darzalex Faspro™ (daratumumab and hyaluronidase-fihj) | Janssen Pharmaceuticals, Inc. |
| Darzalex™ (daratumumab) | Janssen Biotech, Inc. |
| Daurismo™ (glasdegib) | Pfizer, Inc. |
| deferiprone | Taro Pharmaceutical Industries |
| Doptelet® (avatrombopag) | Dova Pharmaceuticals, Inc. |
| Eligard® (leuprolide acetate) | Tolmar Pharmaceuticals, Inc. |
| Empliciti™ (elotuzumab) | Bristol-Myers Squibb Company |
| Enhertu® (fam-trastuzumab deruxtecan-nxki) | AstraZeneca, Diachii Sankyo |
| Epogen® (epoetin alfa) | Amgen, Inc. |
| Erbitux® (cetuximab) | Lilly USA |
| Erivedge™ (vismodegib) | Genentech USA, Inc. |
| Erleada™ (apalutamide) | Janssen Biotech, Inc. |
| Exjade® (deferasirox) | Novartis Pharmaceuticals Corp. |
| Firmagon® (degarelix) | Ferring Pharmaceuticals, Inc. |
| Folotyn™ (pralatrexate) | Spectrum Pharmaceuticals, Inc. |
| Fulphila™ (pegfilgrastim-jmdb) | Mylan Pharmaceuticals |
| Gazyva® (obinutuzumab) | Genentech USA, Inc. |
| Gilotrif® (afatinib) | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Gleevec® (imatinib mesylate) | Novartis Pharmaceuticals Corp. |
| Granix® (tbo-filgrastim) | Cephalon, Inc. |
| Halaven® (eribulin mesylate) | Eisai, Inc. |
| Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk) | Genentech USA, Inc. |
| Herceptin® (trastuzumab) | Genentech USA, Inc. |
| Herzuma® (trastuzumab-pkrb) | Teva Pharmaceuticals USA, Inc. |
| Hycamtin® (topotecan injection) | Novartis Pharmaceuticals Corp. |
| Hycamtin® Oral (topotecan) | Novartis Pharmaceuticals Corp. |
| Ibrance® (palbociclib) | Pfizer, Inc. |
| Idhifa® (enasidenib) | Celgene Corporation |
| Imfinzi® (durvalumab) | AstraZeneca |
| Imjudo® (tremelimumab) | AstraZeneca |
| Inlyta® (axitinib) | Pfizer, Inc. |
| Inqovi® (decitabine and cedazuridine) | Taiho |
| Inrebic® (fedratinib) | Celgene Corporation |
| Iressa® (gefitinib) | AstraZeneca |
| Istodax® (romidepsin) | Celgene Corporation |
| Ixempra™ (ixabepilone) | R-PHARM US |
| Jadenu Sprinkles® (DEFERASIROX Sprinkles) | Novartis Pharmaceuticals Corp. |
| Jadenu® (deferasirox) | Novartis Pharmaceuticals Corp. |
| Jakafi® (ruxolitinib) | Incyte Corporation |
| Jaypirca™ (pirtobrutinib) | Eli Lilly & Co. |
| Jemperli (dostarlimab-gxly) | GSK, Inc. |
| Jevtana® (cabazitaxel) | Sanofi |
| Kadcyla™ (ado_trastuzumab) | Genentech USA, Inc. |
| Kanjinti™ (trastuzumab-anns) | Amgen, Inc. |
| Keytruda® (pembrolizumab) | Merck & Co., Inc. |
| Kisqali® (ribociclib) | Novartis Pharmaceuticals Corp. |
| Kisqali® Femara® Co-pack (ribociclib, letrozole) | Novartis Pharmaceuticals Corp. |
| Kyprolis® (carfilzomib) | Amgen, Inc. |
| Lenvima® (lenvatinib) | Eisai, Inc. |
| Leukine® (sargramostim) | Partner Therapeutics, Inc. |
| Lonsurf (trifluridine and tipiracil) | Taiho Oncology, Inc. |
| Lorbrena® (lorlatinib) | Pfizer, Inc. |
| Lumakras™ (sotorasib) | Amgen, Inc. |
| Lunsumio™ (mosunetuzumab) | Genentech USA, Inc. |
| Lupron Depot® (leuprolide acetate) | AbbVie, Inc. |
| Lynparza™ (olaparib) | AstraZeneca |
| Mekinist® (trametinib) | Novartis Pharmaceuticals Corp. |
| Mektovi® (binimetinib) | Pfizer, Inc. |
| Mozobil™ (plerixafor) | Sanofi |
| Mulpleta® (lusutrombopag) | Shionogi, Inc. |
| Mvasi™ (bevacizumab-awwb) | Amgen, Inc. |
| Mylotarg™ (gemtuzumab ozogamicin) | Pfizer, Inc. |
| Nerlynx™ (neratinib) | Puma Biotechnology, Inc. |
| Neulasta® (pegfilgrastim) | Amgen, Inc. |
| Neulasta® (pegfilgrastim) Onpro® kit | Amgen, Inc. |
| Neupogen® (filgrastim) | Amgen, Inc. |
| Nexavar® (sorafenib) | Bayer |
| Ninlaro® (ixazomib) | Millennium Pharmaceuticals, Inc. |
| Nivestym® (filgrastim-aafi) | Pfizer, Inc. |
| Novantrone® (mitoxantrone) | EMD Serono, Inc. and OSI Pharmaceuticals, Inc. |
| Nplate™ (romiplostim) | Amgen, Inc. |
| Nubeqa® (darolutamide) | Bayer |
| Nyvepria™ (pegfilgrastim-apgf) | Pfizer, Inc. |
| Odomzo® (sonidegib) | Sun Pharma |
| Ogivri™ (trastuzumab-dkst) | Mylan Pharmaceuticals |
| Onureg® (azacitidine) | Celgene Corporation |
| Opdivo® (nivolumab) | Bristol-Myers Squibb Company |
| Opdualag™ (nivolumab and relatlimab-rmbw) | Bristol-Myers Squibb Company |
| PadCev® (enfortumab vedotin-ejfv) | Seagen, Inc. |
| pazopanib | Apotex |
| Pegasys® (peginterferon alfa-2a) | Genentech USA, Inc. |
| Perjeta™ (pertuzumab) | Genentech USA, Inc. |
| Phesgo™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) | Genentech USA, Inc. |
| Piqray® (alpelisib) | Novartis Pharmaceuticals Corp. |
| Polivy™ (polatuzumab vedotin-piiq) | Genentech USA, Inc. |
| Pomalyst® (pomalidomide) | Celgene Corporation |
| Portrazza® (necitumumab) | Eli Lilly & Co. |
| Procrit® (epoetin alfa) | Janssen Biotech, Inc. |
| Proleukin® (aldesleukin) | Prometheus Laboratories, Inc. |
| Promacta® (eltrombopag) | Novartis Pharmaceuticals Corp. |
| Releuko® (filgrastim-ayow) | Kashiv BioSciences, LLC |
| Retacrit™ (epoetin alfa-ebpx) | Pfizer, Inc. |
| Retevmo™ (selpercatinib) | Eli Lilly & Co. |
| Revlimid® (lenalidomide) | Celgene Corporation |
| Riabni™ (Rituximab-arrx) | Amgen, Inc. |
| Rituxan Hycela™ (rituximab hyaluronidase) | Genentech USA, Inc. |
| Rituxan® (rituximab) | Genentech, Inc. and Biogen, Inc. |
| Rozlytrek® (entrectinib) | Genentech USA, Inc. |
| Rubraca® (rucaparib) | Clovis Oncology |
| Ruxience™ (rituximab-pvvr) | Pfizer, Inc. |
| Rybrevant™ (amivantamab-vmjw) | Janssen Biotech, Inc. |
| Rydapt® (midostaurin) | Novartis Pharmaceuticals Corp. |
| Sandostatin LAR® (octreotide acetate) | Novartis Pharmaceuticals Corp. |
| Sandostatin® (octreotide acetate) | Novartis Pharmaceuticals Corp. |
| Scemblix® (asciminib) | asciminib |
| Sprycel® (dasatinib) | Bristol-Myers Squibb Company |
| Stimufend® (pegfilgrastim-fpgk) | Fresenius Kabi USA, LLC |
| Stivarga® (regorafenib) | Bayer HealthCare Pharmaceuticals |
| Sutent® (sunitinib malate) | Pfizer, Inc. |
| Sylvant® (siltuximab) | Janssen Biotech, Inc. |
| Tabrecta™ (capmatinib) | Novartis Pharmaceuticals Corp. |
| Tafinlar® (dabrafenib) | Novartis Pharmaceuticals Corp. |
| Tagrisso® (osimertinib) | AstraZeneca |
| Talzenna® (talazoparib) | Pfizer, Inc. |
| Tarceva® (erlotinib) | Genentech, Inc. and OSI Pharmaceuticals, Inc. |
| Targretin® (bexarotene) | Eisai, Inc. |
| Tasigna® (nilotinib) | Novartis Pharmaceuticals Corp. |
| Tecentriq® (atezolizumab) | Genentech USA, Inc. |
| Temodar® IV (temozolomide) | Merck & Co., Inc. |
| Temodar® Oral (temozolomide) | Merck & Co., Inc. |
| Thalomid® (thalidomide) | Celgene Corporation |
| Thyrogen (thyrotropin alfa for injection) | Genzyme Corporation |
| Tivdak™ (tisotumab vedotin-tftv) | Seagen, Inc. |
| Torisel® (temsirolimus) | Pfizer, Inc. |
| Trazimera™ (trastuzumab-qyyp) | Pfizer, Inc. |
| Treanda® (bendamustine hydrochloride) | Teva Pharmaceuticals USA, Inc. |
| Truxima® (rituximab-abbs) | Teva Pharmaceuticals USA, Inc. |
| Tykerb® (lapatinib) | Novartis Pharmaceuticals Corp. |
| Udenyca® (pegfilgrastim-cbqv) | Coherus BioSciences, Inc. |
| Valchlor® (mechlorethamine) | Helsinn Therapeutics US, Inc. |
| Vectibix® (panitumumab) | Amgen, Inc. |
| Velcade® (bortezomib) | Millennium Pharmaceuticals, Inc. |
| Verzenio™ (abemaciclib) | Eli Lilly & Co. |
| Vidaza® (azacitidine) | Celgene Corporation |
| Vitrakvi® (larotrectinib) | Bayer |
| Vizimpro® (dacomitinib) | Pfizer, Inc. |
| Votrient™ (pazopanib) | Novartis Pharmaceuticals Corp. |
| Xalkori® (crizotinib) | Pfizer, Inc. |
| Xeloda® (capecitabine) | Genentech USA, Inc. |
| Xgeva™ (denosumab) | Amgen, Inc. |
| Xtandi® (enzalutamide) | Astellas Pharma US, Inc. and Medivation, Inc. |
| Yervoy™ (ipilimumab) | Bristol-Myers Squibb Company |
| Yonsa® (abiraterone acetate) | Sun Pharma |
| Zaltrap® (ziv_aflibercept) | Sanofi |
| Zarxio® (filgrastim-sndz) | Sandoz Pharmaceuticals, Inc. |
| Zejula® (niraparib) | GSK, Inc. |
| Zelboraf™ (vemurafenib) | Genentech USA, Inc. |
| Ziextenzo™ (pegfilgrastim-bmez) | Sandoz Pharmaceuticals, Inc. |
| Zirabev® (bevacizumab-bvzr) | Pfizer, Inc. |
| Zoladex® (goserelin) | AstraZeneca |
| Zolinza® (vorinostat) | Merck & Co., Inc. |
| Zometa® (zoledronic acid) | Novartis Pharmaceuticals Corp. |
| Zydelig® (idelalisib) | Gilead Sciences, Inc. |
| Zykadia® (ceritinib) | Novartis Pharmaceuticals Corp. |
| Zytiga® (abiraterone acetate) | Janssen Biotech, Inc. |
Financing Your Care
Financial assistance coordination may be available to help with your medication costs, including manufacturer and community programs. Accredo representatives are available to help find a program that may work for you. Here is a list of some of the organizations that may be able to provide financial assistance for cancer treatment:
- Accessia Health (formally Patient Services Inc)
- Cancer Care
- Healthwell Foundation
- Good Days (Chronic Disease Fund)
- Patient Access Network Foundation
- Patient Advocate Foundation Funds – Co-Pay Relief
- The Assistance Fund
Financial Guidance
Life-saving specialty medication can be expensive. Learn how the Accredo teams help individuals find ways to afford the medication they need to survive in this video.
Find Support
There are many organizations that support research and advocacy for cancer. See below for a few of those organizations
Cancer Support Organizations
Meet the Team
Accredo’s oncology care team is dedicated to serving you and we understand the complexity of your condition. Our specialty-trained clinicians are available 24 hours a day, seven days a week to answer any questions.
Why We Do It
Accredo supports patients with chronic and complex conditions and helps them live their best life. Watch our video to learn why we do what we do for our patients.